Cargando…

Diabetes Complications: The MicroRNA Perspective

Detalles Bibliográficos
Autores principales:	Kantharidis, Phillip, Wang, Bo, Carew, Rosemarie M., Lan, Hui Yao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121430/ https://www.ncbi.nlm.nih.gov/pubmed/21709278 http://dx.doi.org/10.2337/db11-0082

Ejemplares similares

MicroRNAs in β-Cell Biology, Insulin Resistance, Diabetes and Its Complications
por: Fernandez-Valverde, Selene L., et al.
Publicado: (2011)

β-Cell MicroRNAs: Small but Powerful
por: Filios, Stephen R., et al.
Publicado: (2015)

MicroRNA in Diabetic Nephropathy: Renin Angiotensin, AGE/RAGE, and Oxidative Stress Pathway
por: Hagiwara, Shinji, et al.
Publicado: (2013)

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions
por: Nathan, David M., et al.
Publicado: (2013)

The American Diabetes Association Diabetes Research Perspective
por: Fonseca, Vivian A., et al.
Publicado: (2012)

Celebrating 30 Years of Research Accomplishments of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
por: Fradkin, Judith E., et al.
Publicado: (2013)

Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture
por: Bornfeldt, Karin E.
Publicado: (2015)

Diabetes Research: A Perspective From the National Institute of Diabetes and Digestive and Kidney Diseases
por: Fradkin, Judith E., et al.
Publicado: (2013)

The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
por: Walgrave, Hannah, et al.
Publicado: (2021)

Are Individuals With Diabetes Seeing Better?: A Long-Term Epidemiological Perspective
por: Klein, Ronald, et al.
Publicado: (2010)

Regulatory role of microRNA on inflammatory responses of diabetic retinopathy
por: Ye, Eun-Ah, et al.
Publicado: (2017)

Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications
por: Nagai, Ryoji, et al.
Publicado: (2012)

Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials
por: Davidson, Jaime A, et al.
Publicado: (2014)

Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs
por: Sakuma, Hiroko, et al.
Publicado: (2020)

Haploinsufficiency of Tumor Suppressor Genes is Driven by the Cumulative Effect of microRNAs, microRNA Binding Site Polymorphisms and microRNA Polymorphisms: An In silico Approach
por: Manikandan, Mayakannan, et al.
Publicado: (2012)

Historical Perspective: Beginnings of the β-Cell: Current Perspectives in β-Cell Development
por: Seymour, Philip A., et al.
Publicado: (2011)

Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer
por: Andersen, Dana K., et al.
Publicado: (2017)

MicroRNA-Based Diagnostics in Heart Diseases: Current Limitations and Future Perspectives
por: Düsing, Philip, et al.
Publicado: (2021)

American Diabetes Association Research Symposium: Diabetes and the Brain
por: Seaquist, Elizabeth R., et al.
Publicado: (2012)

MicroRNA—implications for cancer
por: Sassen, Stefanie, et al.
Publicado: (2007)

American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiome
por: Semenkovich, Clay F., et al.
Publicado: (2015)

MicroRNA and Microvascular Complications of Diabetes
por: Barutta, F., et al.
Publicado: (2018)

The Barrier of Hypoglycemia in Diabetes
por: Cryer, Philip E.
Publicado: (2008)

Stopping Type 1 Diabetes: Attempts to Prevent or Cure Type 1 Diabetes in Man
por: Skyler, Jay S., et al.
Publicado: (2011)

The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2012)

MicroRNA-based therapeutics for optic neuropathy: opportunities and challenges
por: Mak, Heather K., et al.
Publicado: (2021)

The limits of human microRNA annotation have been met
por: Fromm, Bastian, et al.
Publicado: (2022)

Diabetic Retinopathy: Targeting Vasoregression
por: Hammes, Hans-Peter, et al.
Publicado: (2011)

Hypoglycemia in Type 1 Diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2010)

The Paradox of Progress: Environmental Disruption of Metabolism and the Diabetes Epidemic
por: Neel, Brian A., et al.
Publicado: (2011)

Pediatric Diabetic Nephropathy: Novel Insights from microRNAs
por: Lanzaro, Francesca, et al.
Publicado: (2023)

Viral Trigger for Type 1 Diabetes: Pros and Cons
por: Filippi, Christophe M., et al.
Publicado: (2008)

Advantages of genomic complexity: bioinformatics opportunities in microRNA cancer signatures
por: Lussier, Yves A, et al.
Publicado: (2011)

MicroRNA and Diabetic Bone Disease
por: Daamouch, Souad, et al.
Publicado: (2022)

Central Role for Interleukin-2 in Type 1 Diabetes
por: Hulme, Maigan A., et al.
Publicado: (2012)

Nutrient-Sensing Mechanisms in the Gut as Therapeutic Targets for Diabetes
por: Breen, Danna M., et al.
Publicado: (2013)

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis
por: Skyler, Jay S., et al.
Publicado: (2017)

Nutrient Sensing, Autophagy, and Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2012)

Clinical profile of diabetes mellitus in tuberculosis
por: Ogbera, Anthonia Okeoghene, et al.
Publicado: (2015)

The Streetlight Effect in Type 1 Diabetes
por: Battaglia, Manuela, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_886932gg2n7qterejdrmtjr79e